HLA-DR15 is associated with lower age at onset in multiple sclerosis

Annals of Neurology

Volumn 48, Issue 2, 2000, Pages 211-219

  Masterman, Thomas ^a   Ligers, Arturs ^a,c   Olsson, Tomas ^a,b   Andersson, Magnus ^a,b   Olerup, Olle ^a,c   Hillert, Jan ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Center for Molecular Medicine   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; AGE OF ONSET; ALLELES; CHILD; DISEASE PROGRESSION; FEMALE; HLA-DR ANTIGENS; HUMAN; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; PROGNOSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0033862965     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R     Document Type: Article

References (41)

1. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course
2. Human leukocyte antigen studies in multiple sclerosis
3. HLA antigens in black American patients with multiple sclerosis
4. Association between the lack of HLA-DQw6 and the low incidence of multiple sclerosis in Hungarian Gypsies
5. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews
6. Genomewide scan of multiple sclerosis in Finnish multiplex families
7. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex: The Multiple Sclerosis Genetics Group
8. A full genome search in multiple sclerosis
9. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
10. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
11. The natural history of multiple sclerosis
12. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities
13. An immunogenetic heterogeneity in multiple sclerosis
14. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study
15. HLA and prognosis in multiple sclerosis
16. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis
17. Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or -DQ?
18. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis
19. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
20. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation
21. Optic neuritis: Prognosis for multiple sclerosis from MRI, CSF, and HLA findings
22. Multiple sclerosis - More than one disease?
23. Major differences in the dynamics of primary and secondary progressive multiple sclerosis
24. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up
25. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
26. A simple salting out procedure for extracting DNA from human nucleated cells
27. DNA-RFLP methods and interpretation scheme for HLA-DR and DQ typing
28. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
29. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease
30. Statistical aspects of measuring the strength of associations between HLA antigens and diseases
31. Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS
32. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
33. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity
34. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles
35. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population
36. HLA antigens and complotypes in insulin-dependent diabetes mellitus
37. Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, Northern Spain
38. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes
39. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease
40. Multiple sclerosis and HLA class II susceptibility and resistance genes
41. Effect of age at onset and parental disease status on sibling risks for MS